Almirall up 10% on impressive financials

Spanish dermatology specialist Almirall (BME: ALM) was the envy of investors on Monday, with its share price closing 10% higher.

The Barcelona-based company earlier announced its financial results from the first quarter of 2025, which it described as showing strong sales growth in line with expectations, and with the longer-term growth trajectory set out by the company.

Net sales for the quarter increased 15% year-over-year to 284.6 million euros ($316.5 million), while earnings before interest, taxes, depreciation and amortization were 70.9 million euros, a rise of 35%.